2026 Global: Bioabsorbable Vascular Stents Market -Competitive Review (2032) report
Description
The 2026 Global: Bioabsorbable Vascular Stents Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bioabsorbable vascular stents market by geography and historical trend. The scope of the report extends to sizing of the bioabsorbable vascular stents market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, B. Braun SE, Terumo Corporation, Reva Medical, Elixir Medical, Meril Life Sciences, Arterius Limited, and Kyoto Medical Planning are among the ten major companies shaping the bioabsorbable vascular stents market through product innovation, clinical programs, and regulatory advances. Abbott’s Esprit platform builds on prior experience with the Absorb scaffold and has achieved regulatory milestones for below-the-knee indications, positioning Abbott as a leading incumbent leveraging extensive clinical datasets and integrated procedural solutions. Biotronik has advanced both polymeric and magnesium-alloy scaffolds, reporting platforms that aim for predictable resorption within 12 months and securing Breakthrough Device attention for new coronary devices, which underscores its engineering emphasis on radial strength and controlled degradation. Boston Scientific contributes broad interventional expertise and R&D scale, adapting its device and imaging capabilities to support next-generation bioabsorbable approaches and peripheral indications. B. Braun and Terumo extend the competitive landscape through established global distribution, procedural familiarity among physicians, and investments in clinical validation for both coronary and peripheral bioabsorbable solutions, supporting adoption in diverse healthcare settings.
Smaller and specialist companies are accelerating material and design innovations that challenge larger incumbents and expand clinical niches. Reva Medical’s Tyrocore platform and clinical programs such as MOTIV highlight thinner-strut polymeric scaffolds with enhanced visibility and deliverability designed to overcome early-generation limitations, while Elixir Medical focuses on tailored drug‑eluting and bioresorbable polymer technologies to address complex vascular anatomies and durability concerns. Arterius and Kyoto Medical Planning appear frequently in market analyses as active participants in the bioabsorbable segment, contributing novel device concepts and regional trial activity that bolster competition in both coronary and peripheral markets. Meril Life Sciences and other regionally strong suppliers such as Lepu and MicroPort (noted across market reports) combine cost-competitive manufacturing with expanding regulatory clearances to increase access in Asia‑Pacific and emerging markets, a dynamic reflected in market forecasts projecting steady CAGR and geographic growth outside North America and Europe.
Collectively these ten companies reflect a market transitioning from early coronary-focused efforts to diversified peripheral applications, faster-resorbing magnesium alloys, and thinner-strut polymers backed by refined clinical evidence and regulatory pathways. Recent FDA actions and Breakthrough Device designations have created clearer routes to approval for below‑the‑knee and critical limb ischemia indications, benefiting first movers such as Abbott and enabling competitors like Biotronik, Reva, and Elixir to pursue differentiated platforms with improved mechanical profiles and resorption timelines. Market reports identify a moderately concentrated competitive landscape in which top suppliers hold substantial share but specialist innovators drive technological progress, while regional manufacturers expand procurement opportunities—together shaping a bioabsorbable stent market that is technologically diverse and increasingly focused on peripheral vascular indications.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bioabsorbable vascular stents market by geography and historical trend. The scope of the report extends to sizing of the bioabsorbable vascular stents market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, B. Braun SE, Terumo Corporation, Reva Medical, Elixir Medical, Meril Life Sciences, Arterius Limited, and Kyoto Medical Planning are among the ten major companies shaping the bioabsorbable vascular stents market through product innovation, clinical programs, and regulatory advances. Abbott’s Esprit platform builds on prior experience with the Absorb scaffold and has achieved regulatory milestones for below-the-knee indications, positioning Abbott as a leading incumbent leveraging extensive clinical datasets and integrated procedural solutions. Biotronik has advanced both polymeric and magnesium-alloy scaffolds, reporting platforms that aim for predictable resorption within 12 months and securing Breakthrough Device attention for new coronary devices, which underscores its engineering emphasis on radial strength and controlled degradation. Boston Scientific contributes broad interventional expertise and R&D scale, adapting its device and imaging capabilities to support next-generation bioabsorbable approaches and peripheral indications. B. Braun and Terumo extend the competitive landscape through established global distribution, procedural familiarity among physicians, and investments in clinical validation for both coronary and peripheral bioabsorbable solutions, supporting adoption in diverse healthcare settings.
Smaller and specialist companies are accelerating material and design innovations that challenge larger incumbents and expand clinical niches. Reva Medical’s Tyrocore platform and clinical programs such as MOTIV highlight thinner-strut polymeric scaffolds with enhanced visibility and deliverability designed to overcome early-generation limitations, while Elixir Medical focuses on tailored drug‑eluting and bioresorbable polymer technologies to address complex vascular anatomies and durability concerns. Arterius and Kyoto Medical Planning appear frequently in market analyses as active participants in the bioabsorbable segment, contributing novel device concepts and regional trial activity that bolster competition in both coronary and peripheral markets. Meril Life Sciences and other regionally strong suppliers such as Lepu and MicroPort (noted across market reports) combine cost-competitive manufacturing with expanding regulatory clearances to increase access in Asia‑Pacific and emerging markets, a dynamic reflected in market forecasts projecting steady CAGR and geographic growth outside North America and Europe.
Collectively these ten companies reflect a market transitioning from early coronary-focused efforts to diversified peripheral applications, faster-resorbing magnesium alloys, and thinner-strut polymers backed by refined clinical evidence and regulatory pathways. Recent FDA actions and Breakthrough Device designations have created clearer routes to approval for below‑the‑knee and critical limb ischemia indications, benefiting first movers such as Abbott and enabling competitors like Biotronik, Reva, and Elixir to pursue differentiated platforms with improved mechanical profiles and resorption timelines. Market reports identify a moderately concentrated competitive landscape in which top suppliers hold substantial share but specialist innovators drive technological progress, while regional manufacturers expand procurement opportunities—together shaping a bioabsorbable stent market that is technologically diverse and increasingly focused on peripheral vascular indications.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.